s6y Kailera Therapeutics, Inc. EFFECT

Kailera Therapeutics, Inc. EFFECT, filed Apr 16, 2026: primary_doc.xml

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: April 16, 2026 4:00 P.M.
Form: S-1
CIK: 0002096997
Company Name: Kailera Therapeutics, Inc.
File Number: 333-294690